- Home
- BGSF vs CNTX Comparison
BGSF vs CNTX Comparison
Compare BGSF & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGSF
- CNTX
- Stock Information
- Founded
- BGSF 2007
- CNTX 2015
- Country
- BGSF United States
- CNTX United States
- Employees
- BGSF N/A
- CNTX N/A
- Industry
- BGSF Professional Services
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- BGSF Consumer Discretionary
- CNTX Health Care
- Exchange
- BGSF Nasdaq
- CNTX Nasdaq
- Market Cap
- BGSF 54.8M
- CNTX 60.7M
- IPO Year
- BGSF N/A
- CNTX 2021
- Fundamental
- Price
- BGSF $3.08
- CNTX $0.84
- Analyst Decision
- BGSF Strong Buy
- CNTX Strong Buy
- Analyst Count
- BGSF 1
- CNTX 5
- Target Price
- BGSF $9.00
- CNTX $6.50
- AVG Volume (30 Days)
- BGSF 18.4K
- CNTX 257.9K
- Earning Date
- BGSF 05-07-2025
- CNTX 05-07-2025
- Dividend Yield
- BGSF N/A
- CNTX N/A
- EPS Growth
- BGSF N/A
- CNTX N/A
- EPS
- BGSF N/A
- CNTX N/A
- Revenue
- BGSF $272,499,000.00
- CNTX N/A
- Revenue This Year
- BGSF $4.90
- CNTX N/A
- Revenue Next Year
- BGSF N/A
- CNTX N/A
- P/E Ratio
- BGSF N/A
- CNTX N/A
- Revenue Growth
- BGSF N/A
- CNTX N/A
- 52 Week Low
- BGSF $2.91
- CNTX $0.55
- 52 Week High
- BGSF $9.26
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- BGSF 36.18
- CNTX 56.99
- Support Level
- BGSF $2.91
- CNTX $0.80
- Resistance Level
- BGSF $3.10
- CNTX $0.89
- Average True Range (ATR)
- BGSF 0.15
- CNTX 0.11
- MACD
- BGSF 0.01
- CNTX 0.03
- Stochastic Oscillator
- BGSF 18.48
- CNTX 73.80
About BGSF BGSF Inc.
BGSF Inc is a provider of workforce solutions operating primarily in the U.S. across two segments: Property Management and Professional. In the Property Management segment, BGSF offers office and maintenance talent to clients, facilitating their staffing needs with short-term and consulting solutions. The Professional segment specializes in IT, offering skilled professionals in SAP, Workday, and other areas to Fortune 500 companies and consulting firms nationwide. BGSF's workforce services include on-demand assignments, consulting, and managed solutions, allowing clients to flexibly manage their workforce needs. With a focus on converting fixed personnel costs to variable expenses, BGSF enables companies to effectively address fluctuations in demand while optimizing costs.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.